Asia Practice - Life Sciences

Fostering Innovation


 

Life Sciences Practice in Chinese:  亚洲的生命科技业务 

Blank Rome’s Life Science Practice in China assists Chinese and U.S. technology companies, investors, and multinational corporations find and realize business opportunities in China and the United States.

Our attorneys are experienced in structuring a wide variety of complex transactions, such as drug development agreements, material transfer agreements, regulatory matters, patent protection, joint ventures, capital market financing, mergers and acquisitions, dispute resolution, and litigation.

Our China Practice has specific experience in structuring and facilitating technology related transactions, foreign investment models in and out of China and the US, performing due diligence on Chinese and US technology companies, Chinese and U.S. legal issues concerning ordinary and complex transactions, including foreign investment vehicles in China.

We have extensive experience advising China-based businesses on technology, litigation and capital formation transactions and equity listings in the United States.  We also represent China-based clients in resolving disputes with U.S.-based business partners, including in U.S. federal and state courts and international dispute resolution organizations such as the ICC and AAA. 

Our China-based clients are leading companies in a broad range of life science industries that include pharmaceutical, biotechnology, medical device, agriculture, and more generally, energy, clean-tech, natural resources, maritime, transportation, entertainment, technology, manufacturing, real estate, and consumer goods.

Attorneys in our China Practice are fluent in Mandarin and Cantonese and have extensive knowledge of the cultural and legal systems that affect life science, business and investment in mainland China, and other areas in Asia such as Shanghai, Hong Kong, Taiwan, Korea, and Japan. 

We understand the unique needs of Asia-based clients and have and extensive group of attorneys with strong business, finance, and accounting backgrounds who work primarily on China matters.

We also counsel U.S.-based clients on the legal issues involved with entering and developing new markets for their goods and services in China.  Blank Rome’s strong, cooperative relationships with knowledgeable Chinese and other local law firms provide a platform for efficient and comprehensive service.  Through our representation of U.S.-based public and private companies, manufacturers, service providers, issuers, merchants, and investment banking firms, we regularly provide advice in matters such as:

  • Asia-based subsidiaries
  • business registration
  • company secretary
  • custody and maintenance of statutory books
  • direct investment and acquisitions
  • formation of “special purpose” companies
  • liaison with auditors
  • manufacturing, supply, and processing agreements
  • nominee shareholders
  • overseas company registration and correspondence address in Hong Kong
  • patents, trademark, and other intellectual property
  • private company mergers, acquisitions, and disposals
  • project financing
  • registered office (for companies incorporated in Hong Kong)
  • representation of entrepreneurs, investors, researchers, and scientists in U.S. immigration matters
  • technology and licensing
  • terms and conditions of business
  • authorized representative (for overseas companies registered in Hong Kong)
  • company searches
  • compliance review of statutory books
  • deregistration
  • distribution and sales agreements
  • international trade issues
  • management services issues
  • multinational joint ventures, mergers and acquisitions
  • outsourcing
  • partnership agreements
  • preparation of memorandum and articles of association
  • process agent
  • ready made (or “off-the-shelf”) companies (Hong Kong and foreign)
  • regulatory compliance
  • structured financings, including PIPE transactions, Form 10 shell mergers, and 144a offerings, including follow-on and secondary offerings
  • temporary and permanent employment of Asian professionals in the U.S., including company transfers
  • venture capital financing